Dr. James A. Reeves Jr., MD

  • Ann Arbor, MI
  • Medical oncologist
NPI1447233986
Medicare services, 2020
33,392
Part D claims, 2020
106
Publications
27
Clinical trials
8
Industry payments
$112,208
Practice address
1500 E Medical Center Dr, Ann Arbor, MI 48109
Practice phone
Call (734) 936-4000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

University of Michigan Medical Center

Ann Arbor, Michigan

See all 3 affiliations

Find Dr. Reeves' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. James A. Reeves Jr. is a medical oncologist in Ann Arbor, Michigan

Dr. Reeves practices at University of Michigan Medical Center in Ann Arbor, Michigan.

Dr. Reeves' NPI, 1447233986, was assigned on November 29, 2005. Dr. Reeves graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1982. Dr. Reeves' Florida license number on file is ME53081.

NPI and contact details
NPI enumeration date
November 29, 2005
NPI status
Active
Practice phone
(734) 936-4000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Medical school graduation
1982

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data

Dr. James A. Reeves Jr. practices at University of Michigan Medical Center in Ann Arbor, Michigan

Dr. Reeves' primary practice is University of Michigan Medical Center, at 1500 E Medical Center Dr, Ann Arbor, MI 48109 in Washtenaw County. The practice phone is (734) 936-4000.

  • University of Michigan Medical Center
    1500 E Medical Center Dr, Ann Arbor, MI 48109 · Washtenaw CountyPhone(734) 936-4000

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. James A. Reeves Jr. is affiliated with 2 sites of care and 1 medical group

Dr. Reeves' primary practice is University of Michigan Medical Center in Ann Arbor, Michigan. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Reeves to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Dr. Reeves

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. James A. Reeves Jr.'s practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reeves practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
University of Michigan Medical CenterAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Reeves practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. James A. Reeves Jr. is one of 171 medical oncologists in Michigan

Medical oncology is Dr. Reeves' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Reeves is board certified in hematology by the American Board of Internal Medicine. Dr. Reeves has a license on file in Florida.

Specialties and state licenses

  • Medical oncology, FloridaPrimaryLicense ME53081 · 1988 to 2025 · taxonomy 207RX0202X

Medical oncologists near Dr. Reeves

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. James A. Reeves Jr. billed Medicare for 33,392 services in 2020

CMS data shows 33,392 Medicare services from Dr. Reeves across 49 procedure codes in 2020. Medicare paid $273,585 for them. Every service was in an office.

Medicare services, 202033,392
Paid by Medicare$273,585
Procedure codes49

Dr. Reeves' Medicare services by type, 2019 to 2020

  • 2019
  • 2020
Other services
2019: 372020: 19,13851624%
Drugs given in the office
2019: 10,0472020: 10,4464%
Lab and pathology
2019: 1,2642020: 1,81444%
Tests and treatments
2019: 8042020: 88810%
Surgery
2019: 4352020: 52420%
Office and hospital visits
2019: 4182020: 45810%
Imaging
2019: 862020: 12444%

Dr. Reeves compared with the Michigan median for medical oncologists, 2020

  • Dr. Reeves
  • Michigan median
Medicare services
33,392vs 36491.7 times
Part D claims
106vs 33468% below

Medians across 165 medical oncologists in Michigan with Dmand AI profiles that report each measure.

Dr. Reeves' most billed Medicare procedure codes, 2020

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Reeves

Need commercial claims for Dr. Reeves?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Reeves and other medical oncologists in Michigan.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. James A. Reeves Jr.'s patients have a median age of 65

Across all payers, Dmand AI patient panel data puts Dr. Reeves' median patient age at 65, with 50% women.

Dr. Reeves' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 65

Patient panel by sex, all payers

  • Women50%
  • Men50%

Source: Dmand AI Patient Panel Data

Dr. James A. Reeves Jr. wrote 106 Medicare Part D claims in 2020

In 2020, Dr. Reeves wrote 106 Medicare Part D claims. Every claim was for a generic drug. They cover 7 drugs, with $4,339 in total drug cost. In 2019, CMS named 248 claims across 13 drugs.

Part D claims, 2020106
Drugs named by CMS7
Total drug cost$4,339

Dr. Reeves' most prescribed drugs by claims, 2020

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2019 to 2020

  • 2019
  • 2020
Claims for drugs CMS names
2019: 2482020: 10657%

Drugs named by CMS: 7 in 2020, 13 in 2019.

See all prescribing by Dr. Reeves

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Reeves by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. James A. Reeves Jr. has 27 publications on record

Dmand AI links 27 papers to Dr. Reeves, published from 2012 to 2024. 2017 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Humanized and Bevacizumab. Dr. Reeves has published most often in Blood. Dr. Reeves' most frequent co-authors are Edward R. Arrowsmith, MD, John D. Hainsworth, MD and Ian Winchester Flinn, MD.

Papers27
Years published2012 to 2024

Dr. Reeves' papers by year, 2014 to 2024

Topics Dr. Reeves writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Breast Neoplasms
  • Carcinoma, Renal Cell
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Kidney Neoplasms

Dr. Reeves' most frequent co-authors

Recent publications by Dr. Reeves

See all 27 publications and co-authors

See who Dr. Reeves researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Reeves works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. James A. Reeves Jr. has worked on 8 clinical trials

Dmand AI links Dr. Reeves to 8 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Reeves that name 2 trials.

Clinical trials with Dr. Reeves by phase

  1. 1Phase 1: 1 trial
  2. 1Phase 1/2: 1 trial
  3. 1Phase 2: 1 trial
  4. 2Phase 3: 2 trials
  5. NonePhase 4: no trials

Conditions in Dr. Reeves' trials

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Bronchogenic
  • Breast Neoplasms
  • Carcinoma, Renal Cell
  • Leukemia, Myeloid, Acute

Investigators on the most trials with Dr. Reeves

Recent clinical trials with Dr. Reeves

See all 8 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. James A. Reeves Jr. received $112,208 in industry payments from 2016 to 2024

CMS Open Payments shows 759 general payments to Dr. Reeves from 68 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 68% of the total. Janssen Pharmaceuticals, Inc paid the most, $39,522. It also lists 17 research payments totaling $171,901 from 2016 to 2021, naming 2 clinical trials.

General payments to Dr. Reeves by program year, 2016 to 2024

General payments to Dr. Reeves by kind, 2016 to 2024

$112.2Kin total
  • Speaker and faculty fees$76,53368%
  • Food and beverage$23,01121%
  • Travel and lodging$9,7599%
  • Consulting fees$1,6862%
  • Other$1,2191%

Companies that paid Dr. Reeves the most, 2016 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Reeves

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. James A. Reeves Jr. graduated from LSU Health Sciences Center New Orleans - School of Medicine

Dr. Reeves graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1982.

  1. Medical schoolLSU Health Sciences Center New Orleans - School of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. James A. Reeves Jr. accepts plans from 2 insurance carriers

Dr. Reeves is in network with 2 carriers, including Excellus BlueCross BlueShield and Cigna. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.

  • Excellus BlueCross BlueShield
  • Cigna

Plan types Dr. Reeves accepts, by number of carriers

  1. HMO2
  2. Medicare2
  3. PPO2
  4. EPO1
  5. POS1

Source: Dmand AI Insurance Network Data

Sources for Dr. James A. Reeves Jr.'s profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. James A. Reeves Jr.

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. James A. Reeves Jr.'s NPI number?

Dr. James A. Reeves Jr.'s NPI number is 1447233986. It was assigned on November 29, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. James A. Reeves Jr.?

Dr. James A. Reeves Jr. is a medical oncologist in Ann Arbor, Michigan. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. James A. Reeves Jr. practice?

Dr. Reeves practices at 1500 E Medical Center Dr, Ann Arbor, MI 48109. Dr. Reeves' primary practice is University of Michigan Medical Center in Ann Arbor, Michigan. Dmand AI also links Dr. Reeves to 1 group practice or clinic.

What is Dr. James A. Reeves Jr.'s office phone number?

The practice phone on file for Dr. Reeves is (734) 936-4000.

What is Dr. James A. Reeves Jr.'s medical license number?

Dr. Reeves' Florida license number on file is ME53081.

What medical group is Dr. James A. Reeves Jr. part of?

Dr. Reeves is linked to Florida Cancer Specialists & Research Institute.

Does Dr. James A. Reeves Jr. accept Medicare?

Yes. CMS data shows Dr. Reeves billed Medicare for 33,392 services in 2020.

Is Dr. James A. Reeves Jr. board certified?

Yes. Dr. Reeves is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. James A. Reeves Jr. bill to Medicare?

In 2020, Dr. Reeves' most billed Medicare services were medicare temporary code (Q0138), medicare temporary code (Q9967) and injected or infused drug (J0185).

Where did Dr. James A. Reeves Jr. go to medical school?

Dr. Reeves graduated from LSU Health Sciences Center New Orleans - School of Medicine in 1982.

Show 6 more questionsShow fewer questions

What drugs does Dr. James A. Reeves Jr. prescribe most?

In 2020 Medicare Part D data, Dr. Reeves' most prescribed drugs by claims were Anastrozole, Acyclovir and Fentanyl.

Has Dr. James A. Reeves Jr. received payments from drug or device companies?

CMS Open Payments shows $112,208 in general payments to Dr. Reeves from 68 companies from 2016 to 2024. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. James A. Reeves Jr. been practicing?

Dr. Reeves graduated from medical school in 1982, 44 years ago.

Does Dr. James A. Reeves Jr. do research?

Dmand AI links 27 publications to Dr. Reeves, published from 2012 to 2024. Dr. Reeves has worked on 8 clinical trials.

Who does Dr. James A. Reeves Jr. publish with?

Dr. Reeves' most frequent co-authors are Edward R. Arrowsmith, MD (6 shared papers), John D. Hainsworth, MD (5 shared papers) and Ian Winchester Flinn, MD (4 shared papers).

What insurance does Dr. James A. Reeves Jr. accept?

Dr. Reeves is in network with 2 carriers, including Excellus BlueCross BlueShield and Cigna. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in Michigan by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)